Summary
Unable to assess alignment because the provided AI-generated content is not a drug-label prescribing/usage claim and no direct label-mapped medical assertions were provided to evaluate against the supplied prescribing information.
Category Scores
Accurate Statements
Unsupported Statements
Phenazopyridine is commonly available over the counter in the U.S.
Not supported or addressed in the provided FDA-approved labeling excerpts.
Pricing for phenazopyridine varies by store, tablet strength, and pack size.
Not supported or addressed in the provided FDA-approved labeling excerpts.
Costs can differ based on whether you buy a small, short course pack versus a larger bottle.
Not supported or addressed in the provided FDA-approved labeling excerpts.
In many cases, the generic version of phenazopyridine is less expensive than brand-name Pyridium for the same strength and similar tablet counts.
Not supported or addressed in the provided FDA-approved labeling excerpts.
Drug pricing for many older, widely available drugs is mainly driven by generic availability rather than patent exclusivity.
Not supported or addressed in the provided FDA-approved labeling excerpts.
Contradictions
Important Omissions
Any evaluation-relevant prescribing information claims (e.g., indication, dosage/maximum duration, contraindications, warnings/precautions, interactions, adverse reactions) were not actually stated for audit.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The provided statements concern availability and pricing rather than dosing, safety, or effectiveness; however, they are not label-aligned claims and therefore cannot be verified against the supplied prescribing information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Assessable Against Supplied Label
Primary Issue
The content provided is about OTC availability and pricing, and does not contain auditable prescribing/usage/safety claims from the provided FDA label excerpts.
Suggested Improvement
Provide the exact AI-generated medical/prescribing claim(s) to audit and include only those statements intended to be compared to the supplied FDA label sections (e.g., indication wording, dosing duration limits, contraindications, warnings, interactions, adverse reactions).